Injectable chemotherapeutic microspheres and glioma. I : Enhanced survival following implantation into the cavity wall of debulked tumors

• Published in: Pharmaceutical research 2000-07, Vol.17 (7), p.767-775
• Main Authors: EMERICH, D. F, WINN, S. R, YUNHUA HU, MARSH, J, SNODGRASS, P, LAFRENIERE, D, WIENS, T, HASLER, B. P, BARTUS, R. T
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic agents; Antineoplastic Agents - administration & dosage; Antineoplastic Agents - pharmacokinetics; Biological and medical sciences; Brain cancer; Brain Neoplasms - drug therapy; Brain Neoplasms - metabolism; Brain Neoplasms - mortality; Carboplatin - administration & dosage; Carboplatin - pharmacokinetics; Carmustine - administration & dosage; Chemotherapy; Delayed-Action Preparations; FDA approval; General aspects; Glioma - drug therapy; Glioma - metabolism; Glioma - mortality; Laboratory animals; Male; Medical sciences; Microspheres; Pharmacology. Drug treatments; Polymers; Polymers - administration & dosage; Polymers - pharmacokinetics; Rats; Rats, Inbred F344; Transplants & implants; Tumors
• ISSN: 0724-8741; 1573-904X
• DOI: 10.1023/A:1007576405039

Implantation of biodegradable polymers provides a powerful method to deliver high, sustained concentrations of chemotherapeutics to brain tumors. The present studies examined the ability of injectable polymeric microspheres, formulated to release carboplatin or BCNU for 2-3 weeks, to enhance survival in a rodent model of surgically-resected glioma. Rat glioma (RG2) cells were implanted into the cortex of rats and allowed to grow for 10 days prior to surgical resection. Rats were given either surgical resection only, bolus injection (100 microg) or microspheres containing 10, 50, or 100 microg of carboplatin or BCNU. The microspheres were implanted, via hypodermic injection, either directly into the surgical cavity or into the tissue along the perimeter of the cavity. The order of survival among treatment groups was: no resection < resection only < bolus chemotherapy < sustained release chemotherapy. Carboplatin and BCNU did not differ in this respect and in each case, the enhanced survival achieved with sustained release was dose-related. However, the enhanced survival achieved with carboplatin was substantially greater when the microspheres were implanted into the perimeter wall of the resection cavity, compared to implantation into the cavity itself. The enhanced survival produced by carboplatin implants along the resection perimeter was associated with a significant attenuation of regrowth of the tumor. Finally, in a separate study in non-tumor brain, atomic absorption spectrophotometry revealed that while the microspheres produced significantly prolonged tissue levels of carboplatin relative to a bolus injection, carboplatin diffusion was limited to brain tissue extending primarily 0.5 mm from the injection site. These data demonstrate: (1) that sustained delivery of chemotherapy is superior to equipotent bolus doses following tumor resection, and (2) that direct injection of sustained release microspheres into the tissue surrounding a growing tumor mass may provide superior effects over injections into the surgical cavity. They also suggest that successful implementation of this approach in humans may require measures or circumstances that improve upon the limited spatial drug diffusion from the implantation site.